Andere talen CannaPharmaRX, Inc.

Aandelen

CPMD

US13765D1090

Beurs gesloten - OTC Markets Andere beurzen 19:46:00 17-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^USD	-31,03%		0,00%	+488,24%

14/03	CannaPharmaRX, Inc. Ontvangt eerste inkooporder en begint met de verzending van het product	CI
05/03	CannaPharmaRX, Inc. Sluit meerjarige leveringsovereenkomst met Ican om distributienetwerk op te zetten in Latijns-Amerika	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

CannaPharmaRX, Inc. Receives First Purchase Order and Begins Shipment of Product	14/03
CannaPharmaRX, Inc. Executes Multi-Year Supply Agreement with Ican to Create Distribution Network in the Latin Americas	05/03
CannaPharmaRx, Inc Enters into Strategic Supply Agreement with Cantek Holdings	16/02
CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11
CannaPharmaRX, Inc. Announces Executive Changes	13-10-23
CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13-10-23
CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	22-09-23
CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01-09-23
CannaPharmaRx Expands Board of Directors	25-08-23
CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-06-23
CannaPharmaRX, Inc. Announces CEO Changes	23-06-23
CannaPharmaRX, Inc. Signs Supply Agreement with Y.S.A Holdings for Up to $15 Million Annually of Commercial Cannabis	30-03-23
CannaPharmaRX, Inc. completed the acquisition of LTB Management LLC.	21-03-23
CannaPharmaRX, Inc. agreed to acquire LTB Management LLC.	21-02-23
CannaPharmaRx Receives Canada Revenue Agency License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected	11-01-23
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	22-12-22
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	21-12-22
CannaPharmaRx, Inc Receives Cultivation License from Health Canada and Projects 2023 Revenue over $30 Million	21-12-22
CannaPharmaRX, Inc. Provides Revenue Guidance for the Full Year 2023	21-12-22
CannaPharmaRx, Inc. Receives Cultivation License from Health Canada	21-12-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CannaPharmaRX, Inc.

Aandelen

CPMD

US13765D1090

Andere talen

Filters